Cutler Group LP Sorrento Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 04, 2022	SELL	$1.24 - $2.33 $744 - $1,398	-600 Reduced 85.71%	100 $0
Q1 2022 Apr 14, 2022	BUY	$2.0 - $4.9 $1,200 - $2,940	600 Added 600.0%	700 $1,000
Q1 2021 Apr 26, 2021	SELL	$7.03 - $16.51 $13,357 - $31,369	-1,900 Reduced 95.0%	100 $0
Q4 2020 Jan 21, 2021	SELL	$5.76 - $11.95 $160,704 - $333,405	-27,900 Reduced 93.31%	2,000 $3,000
Q3 2020 Oct 27, 2020	BUY	$6.17 - $18.82 $128,336 - $391,456	20,800 Added 228.57%	29,900 $39,000
Q2 2020 Jul 22, 2020	BUY	$1.73 - $6.76 $15,743 - $61,516	9,100 New	9,100 $20,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.